Shares in Thermo Electron Decline 3.7 percent after Robert W. Baird Downgrade | GenomeWeb

NEW YORK, March 30 (GenomeWeb News) - Shares in Thermo Electron were down 3.72 percent, or $.94, at $24.32 in mid-afternoon trading after Robert W. Baird downgraded the stock to "neutral" from "outperform."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.